How does bupropion work as a smoking cessation aid?

Dopamine, learning and motivation.

Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 2× · see citing works

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585 · see citing works

A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation

Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,253 · see citing works

Bupropion: a review of its mechanism of antidepressant activity.

Ascher, J. A., Cole, J. O., Colin, J. N., Feighner, J. P., Ferris, R. M., Fibiger, H. C., Golden, R. N., Martin, P., Potter, W. Z., & Richelson, E. (1995) · PubMed · Cited by 680 · see citing works

Role of dopamine in the behavioural actions of nicotine related to addiction

Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 680 · see citing works

Dramatic decreases in brain reward function during nicotine withdrawal

Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674 · see citing works

Nicotine maintains robust self-administration in rats on a limited-access schedule

Corrigall, W. A., & Coen, K. M. (1989) · Psychopharmacology · doi:10.1007/bf00589894 · Cited by 578 · see citing works

Bupropion is a nicotinic antagonist

Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509 · see citing works

The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour

Laviolette, S. R., & van der Kooy, D. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1298 · Cited by 452 · see citing works

Cue dependency of nicotine self-administration and smoking

Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A., & Sved, A. F. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00676-1 · Cited by 425 · see citing works

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

Tashkin, D., Kanner, R. E., Bailey, W. C., Buist, S. A., ANDERSON, P. J., Nides, Gonzales, D. H., Dozier, G., Patel, M., & Jamerson, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04724-3 · Cited by 413 · see citing works

Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation: A Randomized, Controlled Trial

Hays, J. T., Hurt, R. D., Rigotti, N. A., Niaura, R., Gonzales, D., Durcan, M. J., Sachs, D. P. L., Wolter, T. D., Buist, A. S., Johnston, J. A., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00011 · Cited by 343 · see citing works

Rodent model of nicotine abstinence syndrome

Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334 · see citing works

Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement

Donny, E. C., Chaudhri, N., Caggiula, A. R., Evans-Martin, F. F., Booth, S., Gharib, M. A., Clements, L. A., & Sved, A. F. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1473-3 · Cited by 304 · see citing works

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism∗

Hayford, K. E., Patten, C. A., Rummans, T. A., Schroeder, D. R., Offord, K. P., Croghan, I. T., Glover, E. D., Sachs, D. P. L., & Hurt, R. D. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.2.173 · Cited by 264 · see citing works

The effect of bupropion on nicotine craving and withdrawal

Shiffman, S. S., Johnston, J. A., Khayrallah, M. A., Elash, C. A., Gwaltney, C. J., Paty, J. A., Gnys, M., Evoniuk, G. E., & DeVeaugh-Geiss, J. (2000) · Psychopharmacology · doi:10.1007/s002130050022 · Cited by 260 · see citing works

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study

Tonstad, S. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00003-4 · Cited by 246 · see citing works

Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.

Ahluwalia, J., Harris, K., Catley, D., Okuyemi, K., & Mayo, M. (2002) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.288.4.468 · Cited by 239 · see citing works

Combined Use of Nicotine Patch and Gum in Smoking Cessation: A Placebo-Controlled Clinical Trial

Kornitzer, M., Boutsen, M., Dramaix, M. W., Thijs, J., & GUSTAVSSON, G. (1995) · Preventive Medicine · doi:10.1006/pmed.1995.1006 · Cited by 230 · see citing works

Conditioned taste aversions and drugs of abuse: A reinterpretation.

Grigson, P. S. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.1.129 · Cited by 228 · see citing works

Environmental stimuli promote the acquisition of nicotine self-administration in rats

Caggiula, A. R., Donny, E. C., White, A., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A., & Sved, A. F. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1156-5 · Cited by 225 · see citing works

Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat

Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223 · see citing works

Dissociating nicotine and nonnicotine components of cigarette smoking

Rose, J. E., Behm, F. M., Westman, E. C., & Johnson, M. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00301-4 · Cited by 222 · see citing works

Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.

Cooper, B. R., Hester, T. J., & Maxwell, R. A. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32266-4 · Cited by 213 · see citing works

The neurobiology of tobacco addiction

Stolerman, I. P., & Shoaib, M. C. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90638-9 · Cited by 195 · see citing works

Evidence that the Acute Behavioral and Electrophysiological Effects of Bupropion (Wellbutrin®) Are Mediated by a Noradrenergic Mechanism

Cooper, B. R., Wang, C. M., Cox, R. F., Norton, R. M., Shea, V., & Ferris, R. M. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.43 · Cited by 184 · see citing works

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

Learned, S. M., Bergström, M., Savitcheva, I., Ascher, J. A., Schmith, V. D., & Långström, B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01834-6 · Cited by 175 · see citing works

Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study

Brody, A. L., Mandelkern, M. A., Lee, G., Smith, E. C., Sadeghi, M., Saxena, S., Jarvik, M. E., & London, E. D. (2004) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2003.12.006 · Cited by 153 · see citing works

Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers

Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Stone, C., Samuels, D., Levin, S. K., Green, S., & Schatzberg, A. F. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.729 · Cited by 146 · see citing works

Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats

Bruijnzeel, A. W., & Markou, A. (2003) · Synapse · doi:10.1002/syn.10242 · Cited by 143 · see citing works

Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study

Gonzales, D. H., Nides, M. A., Ferry, L. H., Kustra, R. P., Jamerson, B. D., Segall, N., Herrero, L. A., Krishen, A., Sweeney, A., Buaron, K., et al. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115750 · Cited by 143 · see citing works

Effectiveness of Bupropion Sustained Release for Smoking Cessation in a Health Care Setting

Swan, G. E., McAfee, T. A., Curry, S. J., Jack, L. M., Javitz, H. S., Dacey, S., & Bergman, K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.19.2337 · Cited by 141 · see citing works

Pharmacokinetics of Bupropion and its Metabolites in Cigarette Smokers versus Nonsmokers

Hsyu, P., Singh, A. K., Giargiari, T. D., Dunn, J. A., Ascher, J. A., & Johnston, J. A. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04361.x · Cited by 137 · see citing works

Bupropion in Depression

Golden, R. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260055007 · Cited by 122 · see citing works

Effect of bupropion on nicotine self-administration in rats

Rauhut, A. S., Neugebauer‎, N. M., Dwoskin, L. P., & Bardo, M. T. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1450-x · Cited by 111 · see citing works

Acute doses of d-amphetamine and bupropion increase cigarette smoking

Cousins, M. S., Stamat, H. M., & de Wit, H. (2001) · Psychopharmacology · doi:10.1007/s002130100802 · Cited by 111 · see citing works

The effect of bupropion sustained-release on cigarette craving after smoking cessation

Durcan, M. J., Deener, G., White, J., Johnston, J. A., Gonzales, D. H., NIAURA, R. S., Rigotti, N. A., & Sachs, D. P. L. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85130-x · Cited by 110 · see citing works

Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum.

Nomikos, G. G., Damsma, G., Wenkstern, D., & Fibiger, H. C. (1992) · PubMed · Cited by 109 · see citing works

Behavioral and biochemical investigations of bupropion metabolites

Bondarev, M. L., Bondareva, T. S., Young, R., & Glennon, R. A. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02010-7 · Cited by 89 · see citing works

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo

Jamerson, B. D. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80023-0 · Cited by 85 · see citing works

Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs.

Suckow, R. F., Smith, T. M., Perumal, A. S., & Cooper, T. B. (1986) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08996-2 · Cited by 85 · see citing works

Investigating the actions of bupropion on dependence-related effects of nicotine in rats

Shoaib, M. C., Sidhpura, N., & Shafait, S. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1277-x · Cited by 84 · see citing works

Bupropion Inhibits Nicotine-Evoked [3H]Overflow from Rat Striatal Slices Preloaded with [3H]Dopamine and from Rat Hippocampal Slices Preloaded with [3H]Norepinephrine

Miller, D. K., Sumithran, S. P., & Dwoskin, L. P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033852 · Cited by 84 · see citing works

Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation

Johnston, J. A., Fiedler‐Kelly, J., Glover, E. D., Sachs, D. P. L., Grasela, T. H., & DeVeaugh-Geiss, J. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110042852 · Cited by 82 · see citing works

Bupropion for Smoking Cessation: A Randomized Trial

Simon, J. A., Duncan, C., Carmody, T. P., & Hudes, E. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.16.1797 · Cited by 81 · see citing works

Pharmacokinetic Optimisation of Sustained-Release Bupropion for Smoking Cessation

Johnston, A. J., Ascher, J. A., Leadbetter, R. A., Schmith, V. D., Patel, D. K., Durcan, M. J., & Bentley, B. (2002) · Drugs · doi:10.2165/00003495-200262002-00002 · Cited by 81 · see citing works

Bupropion: A new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic β-adrenergic, serotonergic (5-HT2), α2-adrenergic, imipramine and dopaminergic receptors in brain

Ferris, R. M. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90198-3 · Cited by 79 · see citing works

Antidepressants Reduce Whole-Body Norepinephrine Turnover While Enhancing 6-Hydroxymelatonin Output

Golden, R. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260060008 · Cited by 76 · see citing works

Antidepressant Profile of Bupropion and three Metabolites in Mice

Martin, P., Massol, J., Colin, J. N., Lacomblez, L., & Puech, A. J. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014505 · Cited by 71 · see citing works

Nicotine and bupropion share a similar discriminative stimulus effect

Young, R., & Glennon, R. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01554-6 · Cited by 70 · see citing works

Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo

Done, C., Silverstone, P. H., & Sharp, T. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90052-6 · Cited by 69 · see citing works

Naturalistic, Self‐Assignment Comparative Trial of Bupropion SR, a Nicotine Patch, or Both for Smoking Cessation Treatment in Primary Care

Gold, P. B., Rubey, R. N., & Harvey, R. T. (2002) · American Journal on Addictions · doi:10.1080/1055049029008811 · Cited by 41 · see citing works

Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile

Martı́nez-Raga, J., Keaney, F., Sutherland, G., Gálvez, B. P., & Strang, J. (2003) · Addiction Biology · doi:10.1080/1355621031000069837 · Cited by 34 · see citing works

Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.

Ferris, R. M., Maxwell, R. A., Br, C., & Soroko, F. E. (1982) · PubMed · Cited by 30 · see citing works

Antidepressants for smoking cessation

Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567 · see citing works

Bupropion: pharmacology and therapeutic applications

Foley, K. F., DeSanty, K. P., & Kast, R. E. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.9.1249 · Cited by 354 · see citing works

Antidepressants for smoking cessation.

Hughes, J., Stead, L., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub4 · Cited by 317 · see citing works

Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent

Dwoskin, L. P., Rauhut, A. S., King‐Pospisil, K. A., & Bardo, M. T. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00178.x · Cited by 259 · see citing works

Stopping Smoking Shortly Before Surgery and Postoperative Complications

Myers, K., Hájek, P., Hinds, C., & McRobbie, H. J. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.97 · Cited by 245 · see citing works

Variation in CYP2A6 Activity and Personalized Medicine

Tanner, J., & Tyndale, R. F. (2017) · Journal of Personalized Medicine · doi:10.3390/jpm7040018 · Cited by 173 · see citing works

The use of bupropion SR in cigarette smoking cessation

Wilkes, S. (2008) · International Journal of COPD · doi:10.2147/copd.s1121 · Cited by 146 · see citing works

The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline: Varenicline For Treatment Of Nicotine Dependence

Foulds, J. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2006.00955.x · Cited by 136 · see citing works

Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor

Dhir, A., & Kulkarni, S. K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.028 · Cited by 133 · see citing works

Treatment of Tobacco Dependence in Mental Health and Addictive Disorders

Hitsman, B. L., Moss, T. G., Montoya, I. D., & George, T. P. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400604 · Cited by 128 · see citing works

Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials

King, D. P., Paciga, S. A., Pickering, E. H., Benowitz, N. L., Bierut, L. J., Conti, D. V., Kaprio, J. A., Lerman, C. E., & Park, P. W. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.232 · Cited by 117 · see citing works

Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis

Smith, P. H., Weinberger, A. H., Zhang, J., Emme, E., Mazure, C. M., & McKee, S. A. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw144 · Cited by 116 · see citing works

Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects.

Piper, M. E., Federman, E. B., McCarthy, D. E., Bolt, D. M., Smith, S. S., Fiore, M. C., & Baker, T. B. (2008) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.117.1.94 · Cited by 105 · see citing works

Negative affective states and cognitive impairments in nicotine dependence

Hall, F. S., Der‐Avakian, A., Gould, T. J., Markou, A., Shoaib, M. C., & Young, J. W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.004 · Cited by 104 · see citing works

Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking

Madden, G. J., & Kalman, D. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq018 · Cited by 101 · see citing works

Psychological mediators of bupropion sustained‐release treatment for smoking cessation

McCarthy, D. E., Piasecki, T. M., Lawrence, D. L., Jorenby, D. E., Shiffman, S. S., & Baker, T. B. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02275.x · Cited by 96 · see citing works

The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats

Shoaib, M. C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.011 · Cited by 93 · see citing works

The endocannabinoid system as a target for addiction treatment: Trials and tribulations

Sloan, M. E., Gowin, J. L., Ramchandani, V. A., Hurd, Y. L., & Foll, B. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.031 · Cited by 90 · see citing works

Smoking-the Bane of Wound Healing

Ahn, C., Mulligan, P., & Salcido, R. (2008) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000305440.62402.43 · Cited by 87 · see citing works

Bupropion improves attention but does not affect impulsive behavior in healthy young adults.

Acheson, A., & de Wit, H. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.16.2.113 · Cited by 82 · see citing works

Effect of Bupropion Treatment on Brain Activation Induced by Cigarette-Related Cues in Smokers

Culbertson, C. S., Bramen, J. E., Cohen, M. S., London, E. D., Olmstead, R. E., Gan, J. J., Costello, M. R., Shulenberger, S., Mandelkern, M. A., & Brody, A. L. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.193 · Cited by 80 · see citing works

Mechanistic insights into nicotine withdrawal

Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works

Bupropion and Bupropion Analogs as Treatments for CNS Disorders

Carroll, F. I., Blough, B. E., Mascarella, S. W., Navarro, H. A., Lukas, R. J., & Damaj, M. I. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00005-6 · Cited by 65 · see citing works

Bupropion for the treatment of nicotine withdrawal and craving

Mooney, M. E., & Sofuoglu, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.965 · Cited by 61 · see citing works

Pharmacogenetics of Nicotine and Associated Smoking Behaviors

Tanner, J., Chenoweth, M. J., & Tyndale, R. F. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_3 · Cited by 55 · see citing works

Atomoxetine Reverses Nicotine Withdrawal-Associated Deficits in Contextual Fear Conditioning

Davis, J. A., & Gould, T. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301315 · Cited by 52 · see citing works

Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment

OʼGara, C., Stapleton, J., Sutherland, G., Guindalini, C., Neale, B. M., Breen, G. D., & Ball, D. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000236328.18928.4c · Cited by 49 · see citing works

Mini-review: The neurobiology of treating substance use disorders with classical psychedelics

Urban, M. M., Stingl, M., & Meinhardt, M. W. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1156319 · Cited by 44 · see citing works

Deeper Insight into the Reducing Biotransformation of Bupropion in the Human Liver

Zemanová, L., Tomanova, R., Havlíková, L., Navrátilová, H., Solich, P., & Wsól, V. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-rg-051 · Cited by 45 · see citing works

Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation

Clark, A., Tate, B., Urban, B., Schroeder, R., Gennuso, S. A., Ahmadzadeh, S., McGregor, D., Girma, B., Shekoohi, S., & Kaye, A. D. (2023) · Health Psychology Research · doi:10.52965/001c.81043 · Cited by 45 · see citing works

Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats

Palmatier, M. I., Levin, M. E., Mays, K. L., Donny, E. C., Caggiula, A. R., & Sved, A. F. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1666-5 · Cited by 40 · see citing works

The current state of tobacco cessation treatment

Choi, H., Ataucuri-Vargas, J., Lin, C., & Singrey, A. M. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20099 · Cited by 39 · see citing works

Dopamine D3receptor ligands for the treatment of tobacco dependence

Foll, B. L., Goldberg, S. R., & Sokoloff, P. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.45 · Cited by 39 · see citing works

Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse

Skike, C. E. V., Maggio, S. E., Reynolds, A. R., Casey, E. M., Bardo, M. T., Dwoskin, L. P., Prendergast, M., & Nixon, K. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.004 · Cited by 39 · see citing works

The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders

Hammond, C. J. (2016) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2016.05.004 · Cited by 38 · see citing works

Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo

Sidhpura, N., Redfern, P. H., Rowley, H. L., Heal, D. J., & Wonnacott, S. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.025 · Cited by 37 · see citing works

Varenicline for smoking cessation: A review of the literature

Kaur, K., Kaushal, S., & Chopra, S. C. (2009) · Current Therapeutic Research · doi:10.1016/j.curtheres.2009.02.004 · Cited by 36 · see citing works

Neuropeptide systems and new treatments for nicotine addiction

Bruijnzeel, A. W. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4513-5 · Cited by 36 · see citing works

CLINICAL AND IMAGING STUDY: Enhanced cue‐elicited brain activation in African American compared with Caucasian smokers: an fMRI study

Okuyemi, K. S., Powell, J. N., Savage, C. R., Hall, S., Nollen, N. L., Holsen, L. M., McClernon, F. J., & Ahluwalia, J. S. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00007.x · Cited by 35 · see citing works

The Role of Mesoaccumbens Dopamine in Nicotine Dependence

Balfour, D. J. K. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_3 · Cited by 34 · see citing works

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

Jones, J. D., Comer, S. D., Metz, V. E., Manubay, J. M., Mogali, S., Ciccocioppo, R., Martinez, S., Mumtaz, M., & Bisaga, A. M. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.10.002 · Cited by 33 · see citing works

Beliefs and attitudes about bupropion: Implications for medication adherence and smoking cessation treatment.

Fucito, L. M., Toll, B. A., Salovey, P., & O’Malley, S. S. (2009) · Psychology of Addictive Behaviors · doi:10.1037/a0015695 · Cited by 33 · see citing works

Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An [11C]raclopride PET study

Egerton, A., Shotbolt, J. P., Stokes, P. R. A., Hirani, E., Ahmad, R., Lappin, J., Reeves, S., Mehta, M. A., Howes, O. D., & Grasby, P. M. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.077 · Cited by 31 · see citing works

Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash

Wright, F., & Rodgers, R. J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3036-6 · Cited by 30 · see citing works

Fitzpatrick's Dermatology in General Medicine

Grover, S., & Grewal, R. (2008) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(08)80108-6 · Cited by 30 · see citing works

Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: Reversal by co‐administration of bupropion

Semba, J., & Wakuta, M. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01822.x · Cited by 28 · see citing works

Combined administration of varenicline and bupropion produces additive effects on accumbal dopamine and abolishes the alcohol deprivation effect in rats

Söderpalm, B., Danielsson, K., de Bejczy, A., Adermark, L., & Ericson, M. (2019) · Addiction Biology · doi:10.1111/adb.12807 · Cited by 23 · see citing works

Carrier-Mediated Transport of the Quaternary Ammonium Neuronal Nicotinic Receptor Antagonist N,N′-Dodecylbispicolinium Dibromide at the Blood-Brain Barrier

Lockman, P. R., Manda, V. K., Geldenhuys, W. J., Mittapalli, R. K., Thomas, F. C., Albayati, Z. A. F., Crooks, P. A., Dwoskin, L. P., & Allen, D. D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130906 · Cited by 22 · see citing works

Varenicline for smoking cessation

Tonstad, S. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.2.121 · Cited by 21 · see citing works

Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal

Wing, V. C., & Shoaib, M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0902-0 · Cited by 21 · see citing works

Why are Antidepressant Drugs Effective Smoking Cessation Aids?

Shoaib, M. C., & Buhidma, Y. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170915142122 · Cited by 20 · see citing works

Review: Nicotinic receptors and stages of nicotine dependence

Brennan, K., Lea, R. A., Fitzmaurice, P. S., & Truman, P. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108100256 · Cited by 20 · see citing works

Continuous-time system identification of a smoking cessation intervention

Timms, K. P., Rivera, D. E., Collins, L. M., & Piper, M. E. (2013) · International Journal of Control · doi:10.1080/00207179.2013.874080 · Cited by 19 · see citing works

Does Extended Pre Quit Bupropion Aid in Extinguishing Smoking Behavior?

Hawk, L. W., Ashare, R. L., Rhodes, J. D., Oliver, J. A., Cummings, K. M., & Mahoney, M. C. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu347 · Cited by 19 · see citing works

An update on the pharmacotherapeutic interventions for smoking cessation

Barboza, J., Patel, R., Patel, P. P., & Hudmon, K. S. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1197203 · Cited by 18 · see citing works

Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial

Tonstad, S., & Aubin, H. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431623 · Cited by 18 · see citing works

Biomarkers to Optimize the Treatment of Nicotine Dependence

Schnoll, R. A., & Leone, F. T. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.91 · Cited by 17 · see citing works

Which is the best primary medication for long-term smoking cessation – nicotine replacement therapy, bupropion or varenicline?

Doggrell, S. A. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.17.2903 · Cited by 16 · see citing works

Rimonabant for treating tobacco dependence.

Steinberg, M. B., & Foulds, J. (2007) · PubMed Central · Cited by 15 · see citing works

Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers

Yardley, M. M., Mirbaba, M., & Ray, L. A. (2015) · CNS Drugs · doi:10.1007/s40263-015-0284-5 · Cited by 14 · see citing works

AXS-05: an investigational treatment for Alzheimer’s disease-associated agitation

Ward, K. M., & Citrome, L. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2096006 · Cited by 12 · see citing works

Dopaminergic genetic variation moderates the effect of nicotine on cigarette reward

Harrell, P. T., Lin, H., Park, J. Y., Blank, M. D., Drobes, D. J., & Evans, D. E. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4116-6 · Cited by 12 · see citing works

Preclinical and clinical research on the discriminative stimulus effects of nicotine

Shoaib, M. C., & Perkins, K. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108063 · Cited by 12 · see citing works

Current and emerging treatment approaches for tobacco dependence

Cummings, K. M., & Mahoney, M. C. (2006) · Current Oncology Reports · doi:10.1007/s11912-006-0077-6 · Cited by 12 · see citing works

Control Systems Engineering for Optimizing Behavioral mHealth Interventions

Rivera, D. E., Martín, C. A., Timms, K. P., Deshpande, S., Nandola, N. N., & Hekler, E. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-51394-2_24 · Cited by 10 · see citing works

Strategies for smoking cessation: what is new and what works?

Cummings, K. M., & Mahoney, M. C. (2008) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2.2.201 · Cited by 10 · see citing works

Smoking, Obesity, and Post-Cessation Weight Gain: Neurobiological Intersection and Treatment Recommendations

Golden, A. K., & Davis, J. M. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s509971 · Cited by 10 · see citing works

PRECLINICAL STUDY: Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice

Gómez, C., Carrasco, C., & Redolat, R. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00099.x · Cited by 9 · see citing works

Oral administration of coenzyme Q10 ameliorates memory impairment induced by nicotine-ethanol abstinence through restoration of biochemical changes in male rat hippocampal tissues

Ahmadi‐Soleimani, S. M., Ghasemi, S., Rahmani, M. A., Gharaei, M., Bezanaj, M. M., & Beheshti, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-61932-4 · Cited by 10 · see citing works

Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats

Malcolm, E. M., Carroll, F. I., Blough, B. E., Damaj, M. I., & Shoaib, M. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3908-z · Cited by 9 · see citing works

Smokers with insomnia symptoms are less likely to stop smoking

Hägg, S. A., Ljunggren, M. E., Janson, C., Holm, M., Franklin, K. A., Gíslason, Þ., Johannessen, A., Jögi, R., Olin, A., Schlünssen, V., et al. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106069 · Cited by 9 · see citing works

Pharmacotherapy for obesity: are we ready to select, tailor and combine pharmacotherapy to achieve more ambitious goals?

Steenackers, N., Toumassian, J., Deleus, E., Mertens, A. C., Lannoo, M., Pazmiño, S., van Laar, A. D. E., der Schueren, B. V., & Vangoitsenhoven, R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1569468 · Cited by 11 · see citing works

The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropion + varenicline in rats

Olsson, Y., Lidö, H. H., Ademar, K., Cadeddu, D., Ericson, M., & Söderpalm, B. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02701-x · Cited by 8 · see citing works

Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia

Montoya, I. D., & Vocci, F. J. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_09 · Cited by 7 · see citing works

Cytochrome P450 enzymes— in vitro , in vivo , and in silico studies

Turpeinen, M. (2006) · Cited by 6 · see citing works

Nicotine Addiction in Schizophrenia, Availability of Better TreatmentOptions as are in General Population

Ahmed, S., Reena, R., Hussain, N., Ahmed, R., Amin, S., Ahmed, S. I., & Washdave (2015) · International Journal of Emergency Mental Health and Human Resilience · doi:10.4172/1522-4821.1000135 · Cited by 4 · see citing works

Effects of varenicline and bupropion on laboratory smoking outcomes: Meta‐analysis of randomized, placebo‐controlled human laboratory studies

Zaso, M. J., & Hendershot, C. S. (2022) · Addiction Biology · doi:10.1111/adb.13218 · Cited by 5 · see citing works

Treatment Options in Smoking Cessation: What Place for Bupropion Sustained-Release?

McCarthy, D. E., Jorenby, D. E., Minami, H., & Yeh, V. M. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2044 · Cited by 5 · see citing works

Therapy for Cessation of Smoking

Bhattacharyya, D., Rai, S., & Neog, L. (2008) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(08)80107-4 · Cited by 5 · see citing works

Smoking cessation: an economic analysis and review of varenicline

Faulkner, M. A. (2009) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s4223 · Cited by 5 · see citing works

Kinetic study and peak purity determination of bupropion hydrochloride using RRLC/DAD and HPLC/MWD methods: stability study and application in pharmaceutical preparation and in synthetic mixtures with nicotine

El-Kosasy, A. M., Hussein, L. A. E.-A., Salama, N. N., & Sedki, N. G. (2015) · RSC Advances · doi:10.1039/c5ra07716h · Cited by 4 · see citing works

Translating the smoking cessation properties of the antidepressant nortriptyline using reinforcing, discriminative and aversive stimulus effects of nicotine in rats

Wing, V. C., & Shoaib, M. C. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2413-2 · Cited by 4 · see citing works

Preclinical Models of Nicotine Withdrawal

Shoaib, M., & Hall, F. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00003-x · Cited by 2 · see citing works

Repurposing prescribed hydromorphone: Alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs

Ivsins, A., Bowles, J. M., Mansoor, M., Kerr, T. H., & Bardwell, G. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104601 · Cited by 3 · see citing works

A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline

Johnson, T. S. (2010) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2010.00550.x · Cited by 3 · see citing works

Targeting Dopaminergic System for Treating Nicotine Dependence.

Abuhamdah, S., Khalil, A., & Sari, Y. (2016) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524916666151104115421 · Cited by 3 · see citing works

Mania possibly linked with bupropion for smoking cessation: A case report

Dwyer, S., & Hieber, R. (2016) · Mental Health Clinician · doi:10.9740/mhc.2016.11.314 · Cited by 3 · see citing works

The effect of smoking cessation on posterior ocular structures

Küçük, B., & Akkaya, S. (2018) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.20180072 · Cited by 3 · see citing works

Peganine isolated from Anisotes trisulcus as a smoking deterrent and anorexigenic agent

Al-Rehaily, J. (2011) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp11.036 · Cited by 3 · see citing works

The dentist's role in smoking cessation management – a literature review and recommendations: part 2

Keat, R., Fricain, J., Catros, S., Monteiro, L. S., Silva, L., Freitas, M. D., Brandariz, A., Lodi, G., Pispero, A., Warnakulasuriya, S., et al. (2018) · Dental Update · doi:10.12968/denu.2018.45.4.298 · Cited by 3 · see citing works

Formulation, Optimization and Characterization of Bupropion Hydrochloride Loaded Nanostructured Lipid Carriers for Intra-Nasal Administration: An Approach to Management of Smoking Cessation

Natarajan, J., Rekharani, A. S., Nidamanuri, B. S. S., Rajendra, P. K. M., Venkatachalam, S., & Selvaraj, J. (2022) · Current Nanomedicine · doi:10.2174/2468187313666221020143555 · Cited by 2 · see citing works

A randomized controlled trial of Bupropion on Nicotine Dependence and Positive and Negative symptoms amongst patients suffering from schizophrenia attending the out-patient department of a tertiary care centre

Parmar, S. J., Kathiriya, B. B., & Mehta, P. (2020) · Indian Journal of Mental Health(IJMH) · doi:10.30877/ijmh.7.1.2020.53-58 · Cited by 2 · see citing works

Cognitive Evaluation of Bupropion Sustained Release in Heavy Tobacco Smokers Using Event-Related Potentials

Uslu, A., Erdem, O., Ergen, M., Özdemir, O., Çuhadaroğlu, Ç., & Demıralp, T. (2012) · Medicina · doi:10.3390/medicina48050034 · Cited by 2 · see citing works

Update on pharmacotherapy for smoking cessation

Choi, H. S., & Kim, J. Y. (2021) · Journal of Korean Medical Association · doi:10.5124/jkma.2021.64.3.216 · Cited by 2 · see citing works

Smoking Cessation Treatment in Primary Care

An, H.-J., Lee, C. M., Seo, Y. B., Lee, E. S., & Paek, Y. (2024) · Korean Journal of Family Practice · doi:10.21215/kjfp.2024.14.4.184 · Cited by 1 · see citing works

Comparison between cytisine and Nicotine Replacement Therapy in smoking cessation among inpatient psychiatric patients

Ardakani, M. T., Sani, Z. G., Beyraghi, N., Najarimoghadam, S., & Kheradmand, A. (2023) · Journal of Addictive Diseases · doi:10.1080/10550887.2023.2237395 · Cited by 1 · see citing works

How soon should alternative smoking cessation treatments be offered after incomplete response to nicotine replacement therapy?

Veldhuizen, S., Yohannes, S., Tang, V. M., Selby, P. L., & Zawertailo, L. A. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112823 · Cited by 1 · see citing works

Preclinical Development and Clinical Implementation of Treatments for Substance Abuse Disorders

Pechnick, R. N., Glasner, S. V., Hrymoc, M., & Wilkins, J. N. (2007) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.5.2.foc151 · Cited by 1 · see citing works

Personality Dimensions, Smoking Behavior and Drug Effects on Nicotine Dependence: Evidence for Predicting Tobacco Withdrawal

Pino, O., Giucastro, G., & Pelosi, A. (2015) · International Journal of Neuroscience and Behavioral Science · doi:10.13189/ijnbs.2015.030202 · Cited by 1 · see citing works

Modern approaches in the treatment of compulsive eating disorders

Marinescu, I. P., Vasiliu, O., & Vasile, D. (2019) · Psihiatru ro · doi:10.26416/psih.57.2.2019.2442 · Cited by 1 · see citing works

Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: Recent preclinical and clinical insights

Paterson, N. E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.009 · Cited by 36 · see citing works

Bupropion の脳内ドパミン神経伝達に及ぼす影響(Bupropion のラット前頭前野、側坐核におけるDA 上昇による抗うつ作用およびニコチン受容体遮断による禁煙補助作用のメカニズム)"

日下, 朗. (2017) · The Academic Repository of The Jikei University School of Medicine (Jikei University School of Medicine)

Bupropion and other non-nicotine pharmacotherapies

Roddy, E. (2004) · BMJ · doi:10.1136/bmj.328.7438.509 · Cited by 89 · see citing works

Bupropionの脳内ドパミン神経伝達に及ぼす影響 (原著)

日下, 朗., 宮田, 久., & 中山, 和. (2017) · Institutional Repositories DataBase (IRDB)

Bupropion

Stolerman, I. P., & Price, L. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_200888